why choose us

First received: October 6, 2022

Clinical Trial: Hydroxyurea Treatment for Adult Sickle Cell Anemia Patients in Kinshasa

Study Status: Completed

Recruit Status: Completed

Condition: Sickle-Cell Anaemia

Study Type: Interventional


Official Title: Diagnosis and Treatment With Hydroxyurea of Sickle Cell Anemia in Democratic Republic of the Congo

Brief Summary: The goal of this clinical trial is to evaluate the efficacy of hydroxyurea (HU) in improving disease severity in adult patients with sickle cell anemia in Kinshasa (Democratic Republic of Congo). This study aims to:assess the safety and efficacy of HU treatment in the Congolese environment;assess the reversibility of chronic cardiac lesions. Participants will take hydroxyurea for two years. The effects of the treatment will be evaluated periodically by clinical evaluation, biological tests, and echocardiographic…

Read more